MRI Evaluation of the Response of Rectal Cancer to Neoadjuvant Chemoradiation Therapy
- 1 March 2019
- journal article
- conference paper
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 39 (2), 538-556
- https://doi.org/10.1148/rg.2019180075
Abstract
MRI plays a critical role in the staging and restaging of rectal cancer. Although newly diagnosed early-stage rectal cancers may immediately be amenable to surgical resection, patients with advanced disease first undergo neoadjuvant therapy that consists of a combination of chemotherapy and radiation therapy. Evaluation of rectal cancer after neoadjuvant therapy is best performed with MRI, given its superior soft-tissue contrast and its ability to allow multiplanar imaging and functional evaluation. In this setting, MRI allows accurate evaluation of primary tumor staging, which is determined on the basis of the depth of invasion within and through the rectal wall and the involvement of adjacent organs. MRI can also be used to evaluate posttreatment morphologic components within the tumors, including fibrosis and mucinous changes that have been shown to correlate with the response to treatment. Additional features such as the circumferential resection margin and extramural vascular invasion—factors shown to affect prognosis and local recurrence—are also assessed before and after therapy. Functional assessment with diffusion-weighted MRI and perfusion MRI plays a role in predicting tumor aggressiveness and the likelihood of response to treatment, as well as the extent of residual tumor after therapy. Lymph node staging is also performed at MRI, with assessment of not only lymph node size but also the internal architecture and signal intensity characteristics. ©RSNA, 2019 See discussion on this article by Wasnik and Al-Hawary.This publication has 75 references indexed in Scilit:
- Magnetic Resonance Imaging–Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY ExperienceJournal of Clinical Oncology, 2011
- Value of ADC measurements for nodal staging after chemoradiation in locally advanced rectal cancer—a per lesion validation studyEuropean Radiology, 2010
- Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03Journal of Clinical Oncology, 2009
- The accuracy of Multi-detector row CT for the assessment of tumor invasion of the mesorectal fascia in primary rectal cancerAbdominal Radiology, 2008
- Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancerBritish Journal of Surgery, 2007
- Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancerJournal of Surgical Oncology, 2006
- Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapyRadiotherapy and Oncology, 2004
- Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imagingJournal of Magnetic Resonance Imaging, 2002
- Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancerBritish Journal of Surgery, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000